These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15095747)

  • 1. Systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis.
    Spence JD
    J Rheumatol; 2004 Apr; 31(4):829. PubMed ID: 15095747
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction. New directions in anti-inflammatory therapy and pain management.
    Hochberg MC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):1-3. PubMed ID: 12528068
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical efficacy of xefocam and its effect on arterial pressure and heart rhythm variability in patients with rheumatoid arthritis in combination with arterial hypertension].
    Tsurko VV; Parnes EIa; Krasnosel'skiĭ MIa
    Ter Arkh; 2002; 74(5):63-6. PubMed ID: 12087911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of indomethacin with felodipine and enalapril.
    Morgan T; Anderson A
    J Hypertens Suppl; 1993 Dec; 11(5):S338-9. PubMed ID: 8158412
    [No Abstract]   [Full Text] [Related]  

  • 6. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of rofecoxib on 24-h ambulatory blood pressure and heart rate monitoring in patients with hypertension and osteoarthritis.
    Derici U; Goker B; Ayerden-Ebinc F; Altok KR; Erten Y; Haznedaroglu S; Aydin M; Arinsoy T; Sindel S
    Int J Tissue React; 2005; 27(2):69-73. PubMed ID: 16035651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
    Wolfe F; Zhao S; Pettitt D
    J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uncritically about Cox-2 inhibitors].
    Håkansson J
    Lakartidningen; 2000 Jul; 97(30-31):3414-5. PubMed ID: 11016214
    [No Abstract]   [Full Text] [Related]  

  • 10. COX-2 inhibitors. New medication for arthritis pain.
    Mayo Clin Health Lett; 1999 Apr; 17(4):7. PubMed ID: 10100465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Alleviating pain and preventing inflammation with selective COX-2 inhibitors. Prescribing with confidence in the future].
    MMW Fortschr Med; 2005 Mar; 147(9):12. PubMed ID: 15794346
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
    Eisen GM; Goldstein JL; Hanna DB; Rublee DA
    Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoarthritis and rheumatoid arthritis: will new data clarify the risk:benefit ratio of cyclooxygenase-2 inhibitors?
    Gogol M
    J Am Geriatr Soc; 2003 Nov; 51(11):1675-6. PubMed ID: 14687407
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current EULAR data on valdecoxib. New study results of gastrointestinal safety and "cost effectiveness"].
    Kellner H
    Krankenpfl J; 2004; 42(5-6):185. PubMed ID: 15527245
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 inhibitors may raise blood pressure.
    Health News; 2005 Jun; 11(6):2. PubMed ID: 16127788
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hypertension in rheumatoid arthritis--relation with the duration of the disease.
    Udayakumar N; Venkatesan S; Rajendiran C
    Int J Cardiol; 2008 Jul; 127(3):410-2. PubMed ID: 17689710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral vascular circulation in patients with rheumatoid arthritis influence of papaverine.
    Batterman RC; Jensen G; Jensen L
    Angiology; 1970 Oct; 21(9):612-26. PubMed ID: 5457224
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular risk and COX-2 inhibition in rheumatological practice.
    Justice E; Carruthers DM
    J Hum Hypertens; 2005 Jan; 19(1):1-5. PubMed ID: 15385947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.